Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KAHAN, Barry D")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 490

  • Page / 20
Export

Selection :

  • and

New developments in organ transplantationKAHAN, Barry D.Transplantation proceedings. 2007, Vol 39, Num 1, issn 0041-1345, 324 p.Serial Issue

Future prospects for immunomodulationKAHAN, Barry D.Transplantation proceedings. 1999, Vol 31, Num 1-2A, issn 0041-1345, 64 p., SUPConference Proceedings

Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimusKAHAN, Barry D.Therapeutic drug monitoring. 2002, Vol 24, Num 1, pp 47-52, issn 0163-4356Conference Paper

Cyclosporine in clinical transplantation and autoimmune disease: [selected papers], Penang, Malaysia, November 12-13, 1989, Kaoshiung, Taiwan, ROC, November 19-20, 1989KAHAN, Barry D.Transplantation proceedings. 1989, Vol 21, Num 3, issn 0041-1345, 5 p. non paginées-113 p. [118 p.]Conference Proceedings

10 Years of mTOR Inhibitor Therapy. A Symposium Honoring Suren SehgalKAHAN, Barry D.Transplantation proceedings. 2003, Vol 35, Num 3A, issn 0041-1345, SUPConference Proceedings

Clinical pharmacokinetics of sirolimusMAHALATI, Kamran; KAHAN, Barry D.Clinical pharmacokinetics. 2001, Vol 40, Num 8, pp 573-585, issn 0312-5963Article

New Dimensions in Transplantation: Weaving the FutureKAHAN, Barry D; PONTICELLI, Claudio.Transplantation proceedings. 1998, Vol 30, Num 5, issn 0041-1345, 910 p.Conference Proceedings

Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy : A consequence of local gl toxicity?ARNS, W.Transplantation proceedings. 2007, Vol 39, Num 1, pp 88-93, issn 0041-1345, 6 p.Article

The Rapamune era of immunosuppression 2003: The journey from the Laboratory to Clinical TransplantationCAMARDO, J.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 18-24, issn 0041-1345, 7 p., SUPConference Paper

Future concepts in transplantationCALNE, R.Transplantation proceedings. 1999, Vol 31, Num 1-2A, pp 21S-24S, issn 0041-1345, SUPConference Paper

Sirolimus in pediatric transplant recipientsSINDHI, R.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 113-114, issn 0041-1345, 2 p., SUPConference Paper

Clinical application of sirolimus in renal transplantation : an updateCHUEH, Shih-Chieh J; KAHAN, Barry D.Transplant international. 2005, Vol 18, Num 3, pp 261-277, issn 0934-0874, 17 p.Article

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: Incidence, risk factors, progression, and prognosisCHUEH, Shih-Chieh J; KAHAN, Barry D.Transplantation. 2003, Vol 76, Num 2, pp 375-382, issn 0041-1337, 8 p.Article

Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipientsLANGER, Robert M; KAHAN, Barry D.Transplantation. 2003, Vol 76, Num 2, pp 318-323, issn 0041-1337, 6 p.Article

Preclinical results of sirolimus treatment in transplant modelsSTEPKOWSKI, S. M.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 219-226, issn 0041-1345, 8 p., SUPConference Paper

Sirolimus rescue therapy for refractory rejection in renal transplantation1,2HONG, Johnny C; KAHAN, Barry D.Transplantation. 2001, Vol 71, Num 11, pp 1579-1584, issn 0041-1337Article

Mechanisms of unresponsiveness to alloantigens in vivoWOOD, K. J.Transplantation proceedings. 1998, Vol 30, Num 5, pp 2430-2431, issn 0041-1345Conference Paper

Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantationTransplantation proceedings. 1998, Vol 30, Num 5, pp 1826-1827, issn 0041-1345Conference Paper

Optimization of cyclosporine therapy in renal transplantationPONTICELLI, C.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1718-1720, issn 0041-1345Conference Paper

Trends in liver transplantation : Hepatocellular cancer and alcoholic liver diseaseWALL, W. J.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1822-1825, issn 0041-1345Conference Paper

SDF-1 plays a key role in the repairing and remodeling process on rat allo-orthotopic abdominal aorta graftsGAO, C; LI, Y.Transplantation proceedings. 2007, Vol 39, Num 1, pp 268-272, issn 0041-1345, 5 p.Article

Bicêtre Hospital experience with sirolimus-based therapy in human renal transplantation: The sirolimus european renal transplant studyCHARPENTIER, B.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 58-61, issn 0041-1345, 4 p., SUPConference Paper

The development of immunosuppression: The rapamycin milestoneCALNE, R. Y.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 15-17, issn 0041-1345, 3 p., SUPConference Paper

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantationKAHAN, B. D.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 37-51, issn 0041-1345, 15 p., SUPConference Paper

Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipientsHRICIK, D. E.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 73-78, issn 0041-1345, 6 p., SUPConference Paper

  • Page / 20